Avidity Biosciences
RNAM
#1919
Rank
S$14.30 B
Marketcap
S$92.58
Share price
0.00%
Change (1 day)
59.11%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: S$14.30 Billion

As of August 2026 Avidity Biosciences has a market cap of S$14.30 Billion. This makes Avidity Biosciences the world's 1919th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026S$14.30 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$204.64 B 1,330.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$131.67 B 820.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S$2.48 B-82.61%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
S$7.74 B-45.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.38 B-97.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$1.04 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
S$13.89 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$4.90 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA